Morgan Stanley Schedule 13G passive stakes

Morgan Stanley and its subsidiary have reported reducing their beneficial ownership in T1 Energy Inc. to below the 5% threshold, as detailed in a Schedule 13G amendment.

Morgan Stanley and its subsidiary have filed an amended Schedule 13G, disclosing a beneficial ownership of 5.8% in Tactile Systems Technology Inc.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have disclosed beneficial ownership of 6.7% of Peakstone Realty Trust's common shares.

Morgan Stanley and its subsidiary have ceased to be beneficial owners of more than five percent of Lantheus Holdings, Inc. common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reported beneficial ownership of 8.6% of Kornit Digital Ltd.'s ordinary shares as of December 31, 2025.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, reported a combined beneficial ownership of 9.1% of Six Flags Entertainment Corporation/NEW common stock.

Morgan Stanley and its subsidiary have reported a 6.0% beneficial ownership in Jianpu Technology Inc. as of December 31, 2025.

Morgan Stanley and its subsidiary have disclosed a 5.3% beneficial ownership stake in Opendoor Technologies Inc. as of December 31, 2025.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have disclosed a combined beneficial ownership of 6.5% in On Holding AG's Class A Ordinary Shares.

Morgan Stanley has filed an amended Schedule 13G, reporting its beneficial ownership in Zymeworks Inc. has fallen to 3.4%.

Morgan Stanley has reduced its beneficial ownership in Turning Point Brands, Inc. to 1.7% of common stock, falling below the 5% reporting threshold.

Morgan Stanley has reported a 6.1% beneficial ownership stake in Radware Ltd, holding over 2.6 million ordinary shares.

Morgan Stanley has reported a 6.5% beneficial ownership stake in Magnera Corp's common stock as of December 31, 2025.

Morgan Stanley and its subsidiary report a 7.1% beneficial ownership stake in Grove Collaborative Holdings, Inc. Class A Common Stock.

Morgan Stanley has reported a 6.0% beneficial ownership stake in Perspective Therapeutics, Inc., holding 4,461,893 shares of common stock.

Morgan Stanley has reduced its beneficial ownership in White Mountains Insurance Group Ltd. to 3.0%, ceasing to be a greater than 5% owner.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have reported a 5.0% beneficial ownership stake in Morgan Stanley Direct Lending Fund.

Morgan Stanley and its subsidiary, Atlanta Capital Management Company, LLC, have each reported reducing their beneficial ownership in Landstar System Inc. to below the 5% threshold.

Morgan Stanley and its subsidiary, Atlanta Capital Management, have amended their Schedule 13G filing for Kirby Corp, reporting beneficial ownership below the 5% threshold.

Morgan Stanley and its subsidiary, Atlanta Capital Management, reported a combined beneficial ownership of 7.6% in Choice Hotels International common stock as of December 31, 2025.

Morgan Stanley and its investment management subsidiary have reported a combined 7.4% beneficial ownership in Black Rock Coffee Bar, Inc.'s Class A Common Stock.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., reported beneficial ownership of 13.5% of Arbutus Biopharma Corp's common shares.

Morgan Stanley and its subsidiary have reported reducing their beneficial ownership in ATRENEW INC's Class A Ordinary Shares to below the 5% threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reported beneficial ownership of 7.0% of Jasper Therapeutics, Inc.'s voting common stock as of December 31, 2025.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have disclosed beneficial ownership of 7.9% of Inhibrx Biosciences, Inc.'s common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have disclosed beneficial ownership of 8.1% of Evolent Health, Inc.'s Class A Common Stock.

Morgan Stanley and its subsidiary have reported a 5.4% beneficial ownership stake in DouYu International Holdings Ltd, as detailed in a recent Schedule 13G filing.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reported a combined beneficial ownership of 5.1% in CervoMed Inc's common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reported reducing their beneficial ownership in AnaptysBio, Inc. to below the 5% threshold.

Morgan Stanley and its subsidiary, Morgan Stanley & Co. LLC, reported a combined beneficial ownership of 9.3% of C4 Therapeutics, Inc.'s common stock as of December 31, 2025.